Gene · 104
Papers2,137
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,137
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nothing in SARS-CoV-2 makes sense except in the light of RNA modification? | Future Virol | 2022 | 35873408 | PubTator, text mining | PubMed |
| RNA-based therapeutics: an overview and prospectus. | Cell Death Dis | 2022 | 35871216 | PubTator, text mining | PubMed |
| Emerging Roles of Long Noncoding RNAs in Breast Cancer Epigenetics and Epitranscriptomics. | Front Cell Dev Biol | 2022 | 35865634 | PubTator, text mining | PubMed |
| ADAR2 enzymes: efficient site-specific RNA editors with gene therapy aspirations. | RNA | 2022 | 35863867 | PubTator, text mining | PubMed |
| Crosstalk of Eight Types of RNA Modification Regulators Defines Tumor Microenvironments, Cancer Hallmarks, and Prognosis of Lung Adenocarcinoma. | J Oncol | 2022 | 35859664 | PubTator, text mining | PubMed |
| Compartment-specific and ELAVL1-coordinated regulation of intronic polyadenylation isoforms by doxorubicin. | Genome Res | 2022 | 35858751 | PubTator, text mining | PubMed |
| ADAR1 downregulation by autophagy drives senescence independently of RNA editing by enhancing p16INK4a levels. | Nat Cell Biol | 2022 | 35851616 | PubTator, text mining | PubMed |
| RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS. | J Biol Chem | 2022 | 35850307 | PubTator, text mining | PubMed |
| Colorectal Cancer Chemotherapy Drug Bevacizumab May Induce Muscle Atrophy Through CDKN1A and TIMP4. | Front Oncol | 2022 | 35847900 | PubTator, text mining | PubMed |
| Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer. | Front Immunol | 2022 | 35837397 | PubTator, text mining | PubMed |
| Next RNA Therapeutics: The Mine of Non-Coding. | Int J Mol Sci | 2022 | 35806476 | PubTator, text mining | PubMed |
| Prolyl Isomerase Pin1 Expression in the Spinal Motor Neurons of Patients With Sporadic Amyotrophic Lateral Sclerosis. | J Clin Neurol | 2022 | 35796272 | PubTator, text mining | PubMed |
| Cas-Based Systems for RNA Editing in Gene Therapy of Monogenic Diseases: In Vitro and in Vivo Application and Translational Potential. | Front Cell Dev Biol | 2022 | 35784464 | PubTator, text mining | PubMed |
| Molecular Biology and Diversification of Human Retroviruses. | Front Virol | 2022 | 35783361 | PubTator, text mining | PubMed |
| The potential of CircRNA1002 as a biomarker in hepatitis B virus-related hepatocellular carcinoma. | PeerJ | 2022 | 35782101 | PubTator, text mining | PubMed |
| Urinary extracellular vesicle as a potential biomarker of exercise-induced fatigue in young adult males. | Eur J Appl Physiol | 2022 | 35781843 | PubTator, text mining | PubMed |
| Methods for recruiting endogenous and exogenous ADAR enzymes for site-specific RNA editing. | Methods | 2022 | 35779766 | PubTator, text mining | PubMed |
| Editome landscape of CCM-derived endothelial cells. | RNA Biol | 2022 | 35771000 | PubTator, text mining | PubMed |
| A nomogram based on A-to-I RNA editing predicting overall survival of patients with lung squamous carcinoma. | BMC Cancer | 2022 | 35768804 | PubTator, text mining | PubMed |
| Crosstalk between angiogenesis and immune regulation in the tumor microenvironment. | Arch Pharm Res | 2022 | 35759090 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/104/papers?page=21